272 related articles for article (PubMed ID: 31444231)
21. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
22. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
[TBL] [Abstract][Full Text] [Related]
23. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
24. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
25. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
26. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
[TBL] [Abstract][Full Text] [Related]
27. Curcumin suppresses LGR5(+) colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway.
Mao X; Zhang X; Zheng X; Chen Y; Xuan Z; Huang P
J Nat Med; 2021 Jun; 75(3):590-601. PubMed ID: 33713277
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
29. DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.
Tanaka K; Ikeda N; Miyashita K; Nuriya H; Hara T
Cancer Sci; 2018 Aug; 109(8):2479-2489. PubMed ID: 29869821
[TBL] [Abstract][Full Text] [Related]
30. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.
Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A
J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541
[TBL] [Abstract][Full Text] [Related]
31. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
32. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
Zhan Y; Qiu Y; Wang H; Wang Z; Xu J; Fan G; Xu J; Li W; Cao Y; Le VM; Ly HT; Yuan Z; Xu K; Yin P
Cancer Sci; 2020 May; 111(5):1619-1630. PubMed ID: 32058643
[TBL] [Abstract][Full Text] [Related]
33. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
34. Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft model.
Yamazaki M; Kato A; Oki E; Zaitsu Y; Kato C; Nakano K; Nakamura M; Sakomura T; Kawai S; Fujii E; Sawada N; Watanabe T; Saeki H; Suzuki M
Lab Invest; 2021 Jan; 101(1):12-25. PubMed ID: 32728120
[TBL] [Abstract][Full Text] [Related]
35. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
36. LGR5 positivity defines stem-like cells in colorectal cancer.
Hirsch D; Barker N; McNeil N; Hu Y; Camps J; McKinnon K; Clevers H; Ried T; Gaiser T
Carcinogenesis; 2014 Apr; 35(4):849-58. PubMed ID: 24282287
[TBL] [Abstract][Full Text] [Related]
37. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
38. Role of Lgr5-positive cells in colorectal cancer.
Ding H; Wang C
Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
40. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway.
Iguchi T; Sakata K; Yoshizaki K; Tago K; Mizuno N; Itoh H
J Biol Chem; 2008 May; 283(21):14469-78. PubMed ID: 18378689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
